Compounds and methods for synthesis and therapy
US6111132A · kind A · utility
41Cited by
17References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 1998 |
| Grant date | Aug 29, 2000 |
| Priority date | — |
| Expiry date | Dec 10, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel compounds of Formula (I) are described. R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are described in this specification. Synthetic intermediates and pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Assay methods for detecting neuraminidase activity are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.